[HTML][HTML] Transcriptional profiling identifies novel regulators of macrophage polarization

KY Gerrick, ER Gerrick, A Gupta, SJ Wheelan… - PloS one, 2018 - journals.plos.org
Macrophages are key inflammatory immune cells that display dynamic phenotypes and
functions in response to their local microenvironment. Major advances have occurred in …

[HTML][HTML] Melatonin: a potential regulator of DNA methylation

K Linowiecka, AT Slominski, RJ Reiter, M Böhm… - Antioxidants, 2023 - mdpi.com
The pineal gland-derived indoleamine hormone, melatonin, regulates multiple cellular
processes, ranging from chronobiology, proliferation, apoptosis, and oxidative damage to …

Cancer's epigenetic drugs: where are they in the cancer medicines?

S Ghasemi - The pharmacogenomics journal, 2020 - nature.com
Epigenetic modulation can affect the characteristics of cancers. Because it is likely to
manipulate epigenetic genes, they can be considered as potential targets for cancer …

DNA methyltransferase inhibitors in cancer: from pharmacology to translational studies

D Pechalrieu, C Etievant, PB Arimondo - Biochemical pharmacology, 2017 - Elsevier
DNA methylation is a mammalian epigenetic mark that participates to define where and
when genes are expressed, both in normal cells and in the context of diseases. Like other …

[HTML][HTML] Epigenetics in breast cancer therapy—New strategies and future nanomedicine perspectives

V Buocikova, I Rios-Mondragon, E Pilalis… - Cancers, 2020 - mdpi.com
Simple Summary Despite advances in cancer treatment, difficult-to-treat tumor subtypes
remain a challenge. New multidisciplinary approaches can help overcome current obstacles …

[HTML][HTML] Epi-drugs in heart failure

E Gorica, SA Mohammed, S Ambrosini… - Frontiers in …, 2022 - frontiersin.org
Unveiling the secrets of genome's flexibility does not only foster new research in the field,
but also gives rise to the exploration and development of novel epigenetic-based therapies …

Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update

P Mondal, J Natesh, D Penta, SM Meeran - Seminars in Cancer Biology, 2022 - Elsevier
Epigenetic modifications are heritable yet reversible, essential for normal physiological
functions and biological development. Aberrant epigenetic modifications, including DNA …

Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities

AD Robinson, ML Eich, S Varambally - Cancer letters, 2020 - Elsevier
Cancer is a disease of uncontrolled cell growth and a major cause of death worldwide. Many
molecular events characterize tumor initiation and progression. Global gene expression …

[HTML][HTML] Multiple myeloma: challenges encountered and future options for better treatment

S Das, N Juliana, NAA Yazit, S Azmani… - International Journal of …, 2022 - mdpi.com
Multiple myeloma (MM) is a malignant hematological disease. The disease is characterized
by the clonal proliferation of malignant plasma cells in the bone marrow. MM accounts for …

[HTML][HTML] Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects

D Neureiter, T Jaeger, M Ocker… - World Journal of …, 2014 - ncbi.nlm.nih.gov
An improvement in pancreatic cancer treatment represents an urgent medical goal. Late
diagnosis and high intrinsic resistance to conventional chemotherapy has led to a dismal …